Print

FDAAdvisoryCommittee.com To Webcast Dec. 1-2 Reviews Of Procter & Gamble's (PG) Sexual Dysfunction Drug Intrinsa, ILEX Oncology, Inc.' (ILXO) Clolar For Leukemia, And INEX Pharmaceuticals (IEX.TO) / Enzon Pharmaceuticals, Inc.'s (ENZN) Marqibo For Lymphoma 
10/19/2005 5:12:19 PM

Breakthrough FDAAdvisoryCommittee.com Webcasts on Dec 1-2 will provide live audio/video access to Food and Drug Administration committee reviews of three new drugs: Ilex' Clolar (Leukemia), Inex/Enzon's Marqibo (Hodgkin's Lymphoma); and Proctor & Gamble's Intrinsa (female sexual dysfunction).
//-->